Search Results - "Moura Leite, Luciana"

Clinico‐pathological features and survival of patients with malignant exocrine pancreatic neoplasms: The AC Camargo Cancer Center experience by Fonseca de Jesus, Victor Hugo, Guedes Camandaroba, Marcos Pedro, Spina Donadio, Mauro Daniel, Cabral, Audrey, Pimentel Muniz, Thiago, Moura Leite, Luciana, Ferreira Sant’Ana, Lucas, Luiz da Costa, Wilson, Curado, Maria Paula, Coimbra, Felipe José Fernandez

“…Background Pancreatic cancer plays an important role in cancer‐related mortality. Few studies have been performed in Brazil to characterize patients affected…”
Get full text

HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer by de Moura Leite, Luciana, Cesca, Marcelle Goldner, Tavares, Monique Celeste, Santana, Debora Maciel, Saldanha, Erick Figueiredo, Guimarães, Paula Tavares, Sá, Daniella Dias Silva, Simões, Maria Fernanda Evangelista, Viana, Rafael Lima, Rocha, Francisca Giselle, Loose, Simone Klog, Silva, Sinara Figueiredo, Pirolli, Rafaela, Fogassa, Camilla Albina Zanco, Mattos, Bruna Raphaeli Silva, Campos, Fernando Augusto Batista, Sanches, Solange Moraes, de Lima, Vladmir Cláudio Cordeiro, Pondé, Noam Falbel

“…Purpose Knowledge on whether low expressions of HER2 have prognostic impact in early-stage breast cancer (BC) and on its response to current chemotherapy…”
Get full text

Real-world data suggest that geriatric assessment fails to stratify risk in treating older adults with lung cancer by Mauro Daniel Spina Donadio, Audrey Cabral F Oliveira, Luciana Leite Moura, Victor Hugo Fonseca de Jesus, Tiago Cordeiro Felisimino, Aldo Lourenço Abbade Dettino

“…Introduction: Older adults require attention to risks of treatment toxicity. The purpose of this study was to evaluate epidemiological data and clinical…”
Get full text

Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma by de Jesus, Victor Hugo Fonseca, Camandaroba, Marcos Pedro Guedes, Donadio, Mauro Daniel Spina, Cabral, Audrey, Muniz, Thiago Pimentel, de Moura Leite, Luciana, Sant'Ana, Lucas Ferreira

“…FOLFIRINOX stands a major breakthrough in the management of metastatic pancreatic adenocarcinoma (MPA). Nonetheless, significant side-effects have been…”
Get full text

Pooling of sputum samples to increase tuberculosis diagnostic capacity in Brazil during the COVID-19 pandemic by Santos, Victor Santana, Allgayer, Manuela Filter, Kontogianni, Konstantina, Rocha, José Erinaldo, Pimentel, Beatriz Jatobá, Amorim, Maria Telma Pinheiro, Duarte, Morgana Valnia Simões Cavalcanti, de Melo Ferreira, Polyanne, Moura, Luciana Coelho Leite, de Lima, Victoria Paulino Santos, Guimarães, Larissa Cândido, Dodd, James, Creswell, Jacob, Cuevas, Luis Eduardo

“…•Testing with Xpert Ultra is expensive.•Testing pooled samples with a single test reduces costs.•Pooling increases tuberculosis testing capacity where the…”
Get full text

Retrospective analysis of efficacy and safety of Gemcitabine-based chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX by de Jesus, Victor Hugo Fonseca, Camandaroba, Marcos Pedro Guedes, Donadio, Mauro Daniel Spina, Cabral, Audrey, Muniz, Thiago Pimentel, de Moura Leite, Luciana, Sant'Ana, Lucas Ferreira

“…Metastatic pancreatic adenocarcinoma (MPA) represents a highly lethal condition. Despite the improvements seen with FOLFIRINOX, there is no randomized data to…”
Get full text

Abstract PS4-40: Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer by Mattos, Bruna RaphaeliSilva, Cesca, Marcelle Goldner, de Moura Leite, Luciana, Tavares, Monique Celeste, Silva, Sinara Figueiredo, Pirolli, Rafaela, Fogassa, Camilla AlbinaZanco, Silva, Erick Figueiredo, Rocha, Francisca Giselle, Loose, Simone Klug, Campos, Fernando AugustoBatista, Sanches, Solange Moraes, de Lima, Vladmir ClaudioCordeiro, Pondé, Noam Falbel

“…Abstract Background: HER2-positive status has for 20 years defined a subgroup of breast cancer (BC) patients who benefit from anti-HER2 therapies. Studies…”
Get full text

Clinical-pathological characterization of patients with HER2 negative breast cancer submitted to adjuvant docetaxel/cyclophosphamide (TC), TC4 versus TC6 by Kraychete, Mila Meyer Campos, de Almeida, Guilherme, Santana, Leonardo, Cesca, Marcelle Goldner, Leite, Luciana de Moura, Tavares, Monique Celeste, Sanches, Solange Moraes

“…e12530 Background: The optimal number of cycles of adjuvant docetaxel and cyclophosphamide (TC) in patients with HER2 negative breast cancer is unknown. The…”
Get full text

Characterization of patients with recurrent breast cancer submitted to neoadjuvant therapy in a Brazilian cancer center by Rossato de Almeida, Guilherme, Tavares, Monique Celeste, Sanches, Solange Moraes, Cesca, Marcelle Goldner, Leite, Luciana de Moura, Lima, Vladmir Cordeiro, Campos, Fernando Augusto Batista

“…e13013 Background: Breast cancer patients submitted to neoadjuvant therapy have clinical-pathological factors that can correlate with favorable outcomes, such…”
Get full text

Influence of access on survival of renal cancer in a Brazilian center by Leite, Luciana de Moura, Dettino, Aldo A., Rinck, José Augusto, Zequi, Stenio Cassio, Loose, Simone, Formiga, Maria Nirvana Cruz

“…Abstract only 644 Background: The introduction of tyrosine kinase inhibitors (TKI) and recently immunotherapy has brought major survival benefits for…”
Get full text

Eficacy and safety of first-line TKI in elderly with metastatic renal cancer by Leite, Luciana de Moura, Rinck, Jose A., Dettino, Aldo A., Zequi, Stenio Cassio, Da Costa, Alexandre Andre B. A., Garcia, Daniel, Formiga, Maria Nirvana

“…Abstract only 588 Background: Data on 1 st line treatment with tyrosine kinase inhibitors (TKI) in elderly patients(pts) with metastatic renal cell carcinoma…”
Get full text

Discordance between molecular subtyping from pre- and post-neoadjuvant chemotherapy (NACT) biopsy specimens in a Brazilian breast cancer cohort by Tavares, Monique Celeste, Leite, Luciana de Moura, Cesca, Marcelle Goldner, de Andrade, Poliana, Pirolli, Rafaela, Xerfan, Mariana Pinheiro, Oliveira, Fernanda A., Silva, Sinara Figueiredo, Zanco Fogassa, Camilla Albina, Mattos, Bruna Raphaeli Silva, Campos, Fernando Augusto Batista, Sanches, Solange Moraes, Cordeiro De Lima, Vladmir Claudio

“…Abstract only e12649 Background: Discordance between immunohistochemistry (IHC) and molecular subtyping from pre and post neoadjuvant chemotherapy (NACT)…”
Get full text